within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AK05_Bedaquiline;
model Bedaquiline 
   extends Pharmacolibrary.Drugs.ATC.J.J04AK05;

  annotation(Documentation(
    info ="<html><body><p>Bedaquiline is a diarylquinoline antimycobacterial agent used for the treatment of multidrug-resistant tuberculosis (MDR-TB). It acts by inhibiting the mycobacterial ATP synthase enzyme and has been approved for use in combination therapy for MDR-TB in adults and some pediatric populations. Bedaquiline is currently approved by regulatory agencies including the FDA and EMA.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in adult patients with multidrug-resistant pulmonary tuberculosis, generally healthy except for TB, mixed sex, studied after oral administration.</p><h4>References</h4><ol><li><p>Zhu, H, et al., &amp; Lu, Y (2021). Population pharmacokinetics of bedaquiline in patients with drug-resistant TB. <i>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</i> 25(12) 1006–1012. DOI:<a href=&quot;https://doi.org/10.5588/ijtld.21.0158&quot;>10.5588/ijtld.21.0158</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34886931/&quot;>https://pubmed.ncbi.nlm.nih.gov/34886931</a></p></li><li><p>Gour, A, et al., &amp; Nandi, U (2021). Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats. <i>ACS omega</i> 6(10) 6934–6941. DOI:<a href=&quot;https://doi.org/10.1021/acsomega.0c06165&quot;>10.1021/acsomega.0c06165</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33748607/&quot;>https://pubmed.ncbi.nlm.nih.gov/33748607</a></p></li><li><p>Jaw-Tsai, S, et al., &amp; Yang, T (2023). Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs. <i>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</i> 27(1) 28–33. DOI:<a href=&quot;https://doi.org/10.5588/ijtld.22.0326&quot;>10.5588/ijtld.22.0326</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36853125/&quot;>https://pubmed.ncbi.nlm.nih.gov/36853125</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Bedaquiline;
